A new oral treatment for psoriatic arthritis, Celgene's Otezla, has been approved in the US. Otezla (apremilast) is Celgene's attempt to break into the immunology field currently dominated by the ...

NICE has issued a final appraisal determination recommending Celgene's Otezla for adults with active psoriatic arthritis, reversing an earlier decision to reject the drug. The oral drug is Celgene ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — a move applauded by experts as they await the impact of the first ...